2. AbbVie Pharmaceuticals (headquartered in Lake Forest, IL) has commenced a $10 million R&D project to...

2. AbbVie Pharmaceuticals (headquartered in Lake Forest, IL) has commenced a $10 million R&D project to develop a new drug to treat a rare disease. So far, it has spent $6 million of the $10 million, and preliminary results are positive. If the additional $4 million is invested, the drug will certainly be completed and is expected to generate profit of $18 million in present value for AbbVie. Meanwhile, a research biologist at Illinois Tech has independently developed a treatment for the same disease. The scientist has offered to sell her invention to AbbVie for $2 million. Her drug would be just as effective as AbbVie’s drug, and would also generate profit of $18 million in present value.

a. Should AbbVie buy the drug for $2 million?

b. What is the most AbbVie should be willing to pay for the Illinois Tech researcher’s drug?

c. How would your answer change if the Illinois Tech biologist had developed her drug two years ago, before AbbVie started its own R&D project?

d. Suppose that Merck has also expressed interest in the biologist’s invention. If Merck buys the drug, there is a 50% chance that it will beat AbbVie’s drug to market. If that happens, suppose the profit of the second drug to market is zero. Now how much should AbbVie be willing to pay for the drug? How much should Merck be willing to pay?

I need help with part d, but would appreciate if the other parts were answered too.

Expert Solution

Rahul Sunny answered 2 years ago

AbbVie Pharmaceuticals (headquartered in Lake Forest, IL) has commenced a $10 million R&D project to develop...

AbbVie Pharmaceuticals (headquartered in Lake Forest, IL) has commenced a $10 million R&D project to develop a new drug to treat a rare disease. So far, it has spent $6 million of the $10 million, and preliminary results are positive. If the additional $4 million is invested, the drug will certainly be completed and is expected to generate profit of $18 million in present value for AbbVie. Meanwhile, a research biologist at Illinois Tech has independently developed a treatment for...

WACC. Grey's Pharmaceuticals has a new project that will require funding of $1.3 million. The company...

WACC. Grey's Pharmaceuticals has a new project that will require funding of $1.3 million. The company has decided to pursue an all-debt scenario. Grey's has made agreements with four lenders for the needed financing. These lenders will advance the following amounts at the interest rates shown: Lender Amount Interest Rate Steven $471,035- 16% Yang $394,713 -13% Shepherd $310,768 -11% Bailey $123,484 -12% What is the weighted average cost of capital for the $1,300,000?

WACC. Grey's Pharmaceuticals has a new project that will require funding of $5.4 million. The company...

WACC. Grey's Pharmaceuticals has a new project that will require funding of $5.4 million. The company has decided to pursue an all-debt scenario. Grey's has made agreements with four lenders for the needed financing. These lenders will advance the following amounts at the interest rates shown: Lender Amount Interest Rate Steven $2,029,278 12% , Yang $1,597,982 11% , Shepherd $1,192,408 8% , Bailey $580,332 9% . What is the weighted average cost of capital for the $5,400,000?

Differentiate between R&D project management and conventional project management.

Mackey Biotechnical, Inc., develops, manufactures, and sells pharmaceuticals. Significant research and development (R&D) expenditures are made...

Mackey Biotechnical, Inc., develops, manufactures, and sells pharmaceuticals. Significant research and development (R&D) expenditures are made for the development of new drugs and the improvement of existing drugs. During 2017, $180 million was spent on R&D. Of this amount, on January 1, 2017, $20 million was spent on the purchase of equipment to be used in a research project involving the development of a new drug. The controller, Margret Davidson, is considering capitalizing the equipment and depreciating it over the...

The Lake Charles Chemicals LLC is considering investing in a new gas to liquids technology. R&D...

The Lake Charles Chemicals LLC is considering investing in a new gas to liquids technology. R&D scientists and engineers are investigating a new liquid-based catalyst system that will enable to operate the reactor at lower temperature and pressure to achieve higher conversion efficiencies. The company expects a three-year R&D period before they start producing the product as a commercial commodity. The following financial information is presented for management review. • R&D Cost: $6.5 million over a three-year period: $1 million...

Green Lake Corp. has 10 million shares outstanding with a market price of $25 per share...

Green Lake Corp. has 10 million shares outstanding with a market price of $25 per share and no debt. The company marginal tax rate is 40%. The CFO of Green Lake plans to issue a $100 million debt and use the proceeds to repurchase the outstanding shares. Assume that Green Lake prepares to repurchase the existing shares from the open market at $25 per share. What will the new share price be after the repurchase?

Green Forest Technology is considering a project that would last for 2 years. The project would...

Green Forest Technology is considering a project that would last for 2 years. The project would involve an initial investment of 76,000 dollars for new equipment that would be sold for an expected price of 77,000 dollars at the end of the project in 2 years. The equipment would be depreciated to 22,000 dollars over 6 years using straight-line depreciation. In years 1 and 2, relevant annual revenue for the project is expected to be 65,000 dollars per year and...

A flood control project has a construction cost of $10 million in year 1; $6 million...

A flood control project has a construction cost of $10 million in year 1; $6 million in year 2; and $2 million in year 3, when it is completed. Beginning in year 4, annual O&M costs are $200,000/year. The interest rate is 6%. Benefits also begin accruing in year 4, valued at $1.5 million that year. Thereafter, the benefits grow at a uniform rate of $30,000/year until the end of the project life of 50 years. Make a cash flow...

Parramore Corp has $10 million of sales, $3 million of inventories, $2 million of receivables, and...

Parramore Corp has $10 million of sales, $3 million of inventories, $2 million of receivables, and $3 million of payables. Its cost of goods sold is 75% of sales, and it finances working capital with bank loans at a 6% rate. Assume 365 days in year for your calculations. What is Parramore's cash conversion cycle (CCC)? Do not round intermediate calculations. Round your answer to two decimal places. days If Parramore could lower its inventories and receivables by 11% each...

Question